Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04079816 · ClinicalTrials.gov registry record

Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025

A clinical trial of Healthy, sponsored by Masimo Corporation.

Completed
Registry status
29
Enrollment target
1
Study location

NCT04079816 is a study of Healthy that has completed, run by Masimo Corporation. The registered enrollment target is 29 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04079816, a study of Healthy, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
29 participants
Enrollment target
1
Study location

Study Summary

ORi is a unitless index that could help clinicians with their assessments or normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and above. In this study, the PaO2 is varied by controlling the concentration of oxygen the study volunteer breathes. Changes in ORi values are analyzed by comparing it to corresponding changes in PaO2 measurements from blood samples.

Conditions Studied

Interventions

  • DEVICE INVSENSOR00025

Study Locations (1)

California

  • Masimo Corporation - Irvine

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2019-08-19
Est. Completion 2019-08-28

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT04079816

The ClinicalTrials.gov registry entry for NCT04079816 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which INVSENSOR00025 is the first listed.

NCT04079816 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04079816 about?

NCT04079816 is a clinical study titled "Oxygen Reserve Index (ORi) Expanded Data Set Validation of INVSENSOR00025". ORi is a unitless index that could help clinicians with their assessments or normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to PaO2 values of 100mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200mmHg and...

What is the current status of trial NCT04079816?

This trial is currently completed. The enrollment target is 29 participants. The study started on 2019-08-19. Estimated completion is 2019-08-28.

What conditions does trial NCT04079816 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT04079816?

The interventions under investigation include: INVSENSOR00025 (DEVICE).

Who is sponsoring clinical trial NCT04079816?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04079816 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.